Elyxium Wealth’s Tarsus Pharmaceuticals TARS Stock Holding History

Elyxium Wealth’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$43.3K	Buy	+551	New	+$38.3K	﹤0.01%	657

Other funds holding TARS

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

E. Ohman J:or Asset Management Stockholm, Sweden $4.47B AUM 27.58% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Elyxium Wealth's TARS Position: Q3 2026 in Review

Elyxium Wealth opened a new position in Tarsus Pharmaceuticals (TARS) in Q3 2026: 551 shares worth $43.3K. The stake represents ﹤0.01% of the portfolio and ranks #657 among its holdings.

46 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

Elyxium Wealth held 551 shares of Tarsus Pharmaceuticals worth $43.3K as of Q3 2026.
Tarsus Pharmaceuticals was a new Elyxium Wealth position in Q3 2026.
Tarsus Pharmaceuticals made up ﹤0.01% of Elyxium Wealth's portfolio in Q3 2026, its #657 holding.
46 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Elyxium Wealth's 13F filing for Q3 2026, filed 27 Oct 2026.